Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
04/08/1992 | EP0479479A1 Imadazole angiotensin II antagonists incorporating acidic functional groups |
04/08/1992 | EP0479210A2 GIP analogues and use thereof |
04/08/1992 | EP0479177A2 4- or 5-substituted pyridine-2-carboxylic acids, process for their preparation and their use as medicaments |
04/08/1992 | EP0478792A1 High-protein high-viscosity alimentary food composition |
04/08/1992 | EP0478787A1 Novel process for producing benzoic acid derivative |
04/08/1992 | EP0478775A1 Peptide derivatives |
04/08/1992 | EP0478558A1 An improved process for the preparation of substituted isoflavone derivatives. |
04/08/1992 | CN1016169B Process for preparing imidazole derivatives |
04/07/1992 | US5102905 For treating side effects of diabetes and galactosemia |
04/07/1992 | US5102900 Imidazoles useful as antiatherosclerotic agents |
04/07/1992 | US5102895 Novel vitamin e derivatives and process for the production thereof |
04/07/1992 | US5102894 Antihyporic, antiischemic, antiepileptic agents |
04/07/1992 | US5102888 Quinoline type mevalonolactones useful for treating hyperlipidemia and related diseases |
04/07/1992 | US5102886 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones and analogs thereof useful as aldose reductase inhibitors |
04/07/1992 | CA1298536C Assay for sulfhydryl amino acids and methods for detecting and distinguishing cobalamin and folic acid deficiency |
04/02/1992 | WO1992005446A1 Cloned glutamic acid decarboxylase |
04/02/1992 | WO1992005180A1 Heterocyclic compounds |
04/02/1992 | WO1992005169A1 (2-thienyl) alkylamine derivatives having neuroprotective properties |
04/02/1992 | WO1992005160A1 4-arylsulfonyl-3,4-dihydro-2(1h)-quinoxalinone-1-alkanoic acids, esters, and salts |
04/02/1992 | CA2052517A1 Imidazole angiotensin ii antagonists incorporating acidic functional groups |
04/02/1992 | CA2052510A1 4- or 5-substituted pyridine-2-carboxylic acids, a process for the preparation thereof and the use thereof as pharmaceuticals |
04/01/1992 | EP0478292A1 Heterocyclic compounds |
04/01/1992 | EP0477885A2 Parathyroid hormone derivatives |
04/01/1992 | EP0477778A2 Benzene, pyridine and pyrimidine derivative |
04/01/1992 | EP0477552A1 Use of 10-membered ring lactones as lipid regulators |
04/01/1992 | EP0477195A1 Suramin type compounds and angiostatic steroids to inhibit angiogenesis |
04/01/1992 | CN1059909A Carbocyclic adenosine analogs useful as immunosuppressants |
03/31/1992 | US5100894 Open chain rifamycin derivatives |
03/31/1992 | CA1298309C Benzocycloheptene derivatives |
03/31/1992 | CA1298201C Method and compositions for treating obesity, depression, drug abuse and narcolepsy |
03/29/1992 | CA2046468A1 Alpha-glucosidase inhibitor, pradimicin q |
03/28/1992 | CA2052287A1 Tricyclic heterocyclic compounds, their production and use |
03/27/1992 | CA2051261A1 Cardiopulmonary bypass and organ transplant using a potassium channel activator |
03/26/1992 | CA2052191A1 Benzene, pyridine and pyrimidine derivative |
03/25/1992 | WO1992004899A1 Methods |
03/25/1992 | EP0476646A1 Calcium uptake inhibitors |
03/25/1992 | EP0476493A1 Acyclic tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia |
03/25/1992 | EP0172880B1 Use of long chain and medium chain triglycerides |
03/25/1992 | CN1059722A 3-aryl-4(3h) quinazolinone cck antagonists and pharmaceutical formulations thereof |
03/25/1992 | CA2092177A1 Methods |
03/24/1992 | US5098930 Heterocyclic derivatives |
03/24/1992 | US5098928 Antilipemic agents and treatment of arteriosclerosis |
03/24/1992 | US5098910 Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs |
03/19/1992 | WO1992005187A1 NEW 17-β-OESTRADIOL DERIVATIVES, A METHOD OF PREPARING THEM, AND DRUGS CONTAINING THEM |
03/19/1992 | WO1992004368A1 Pharmacologically active substance bpc, the process for its preparation and its use in the therapy |
03/19/1992 | WO1992004334A1 Compounds |
03/19/1992 | WO1992004316A1 Phenylethanolamines, drugs containing these compounds, and a method of preparing them |
03/19/1992 | WO1992004038A1 Pro-drugs for cck antagonists |
03/19/1992 | WO1992004033A1 Methods for inhibiting rejection of transplanted tissue |
03/19/1992 | WO1992003925A1 Treatment process for promoting weight loss employing a substituted δ5-androstene |
03/19/1992 | WO1991019704A3 Oxa- and thiazolidinedione hypoglycemic and hypocholesterolemic agents |
03/19/1992 | WO1991019692A3 Calcium citrate malate composition |
03/19/1992 | DE4029499A1 Neue 17-(beta)-oestradiolderivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel New 17- (beta) -oestradiolderivate, process for their production and pharmaceutical compositions containing them |
03/19/1992 | CA2091268A1 17-.beta.-oestradiol derivatives, processes for their preparation and medicaments containing these compounds |
03/19/1992 | CA2090759A1 Treatment process for promoting weight loss employing a substituted 5-androstene |
03/18/1992 | WO1992005163A1 5-trifluoroacylamino-2-aryl oxazoles |
03/18/1992 | EP0475896A1 Polycyclic compounds |
03/18/1992 | EP0475895A1 Acyl derivatives of rifamycins and their use as medicaments |
03/18/1992 | EP0475894A1 Gemfibrozil formulations |
03/18/1992 | EP0475755A1 3-Aryl-4(3H)quinazolinone CCK antagonists and pharmaceutical formulations thereof |
03/18/1992 | EP0475706A1 Novel squalene synthetase inhibitors |
03/18/1992 | EP0475413A2 Carbocyclic nucleoside analogs useful as immunosuppressants |
03/18/1992 | EP0475411A1 Novel carbocyclic adenosine analogs useful as immunosuppressants |
03/18/1992 | EP0475148A1 Pravastatin alone or in combination with a fibric acid derivative for preventing onset of or treating type III hyperlipoproteinemia |
03/18/1992 | EP0474733A1 Antihyperlipidemic and antiatherosclerotic urea compounds. |
03/18/1992 | EP0198901B1 Method for preparing 1alpha-hydroxyvitamin d compounds |
03/18/1992 | CN1059522A Stabilization and recovery method for to cotrienol and to copherol products |
03/18/1992 | CN1059517A Acetamide derivatives |
03/18/1992 | CA2090857A1 5-trifluoroacylamino-2-aryloxazoles 2-aryl-5-trifluoroacylaminooxazoles |
03/17/1992 | US5097023 α-glucosidase inhibitors |
03/17/1992 | US5096921 Organic compounds |
03/17/1992 | US5096918 Aldose reductase inhibitors, diabetes, galactosemia |
03/17/1992 | US5096914 Novel benzopyran derivatives, processes for their preparation and their use and preparations containing the compounds |
03/17/1992 | US5096713 Retinoic esters of l-cladinose, process for their preparation and their use in human of veterinary medicine and in cosmetic compositions |
03/17/1992 | CA1297410C Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same |
03/15/1992 | CA2051229A1 Hypocholesterolemic unsymmetrical dithiol ketals |
03/15/1992 | CA2050514A1 Acyclic tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia |
03/14/1992 | CA2050994A1 3-aryl-4(3h)quinazolinone cck antagonists and pharmaceutical formulations thereof |
03/14/1992 | CA2050739A1 Squalene synthetase inhibitors |
03/12/1992 | DE4028398A1 Phenylethanolamine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung Phenylethanolamine, pharmaceutical compositions containing them and methods for their manufacture |
03/11/1992 | WO1992004321A1 Substituted bicyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity |
03/11/1992 | WO1992004040A1 Treatment of obesity with an alpha-2-adrenergic agonist and a growth hormone releasing peptide |
03/11/1992 | EP0474358A2 Use of conduritol to inhibit an increase in blood sugar level |
03/11/1992 | EP0474291A1 HMG-COA reductase inhibitor metabolites |
03/11/1992 | EP0474109A1 New 5-benzyl-substituted benzimidazolin-2-thion derivatives and process for their preparation |
03/11/1992 | EP0473626A1 New diphosphonic acid derivatives, process for producing them and drugs containing them. |
03/11/1992 | EP0466768A4 Short-chain triglycerides |
03/11/1992 | CA2091257A1 Substituted bicyclic aryl compounds exhibiting selective leukotriene b4 antagonists activity |
03/10/1992 | US5095115 Preparation of riboflavin 5'-phosphate (fmn) and its sodium salt in a lactone |
03/10/1992 | CA1297035C Chewable, non-gritty calcium citrate tablet |
03/10/1992 | CA1297034C Liquid calcium supplementation from readily soluble mixtures of calciumcompound and citric acid |
03/07/1992 | CA2050730A1 Spiro (4.5) decane derivatives, method for preparing them and pharmaceutical compounds containing them |
03/05/1992 | WO1992003733A1 Methods and compositions for early detection and treatment of insulin dependent diabetes mellitus |
03/05/1992 | WO1992003420A1 Spiro[cycloalkylbenzene-1,1'-(1',2',3',4'-tetrahydroisoquinolines)] having neuroprotective properties |
03/05/1992 | WO1992003414A1 Novel vitamin d analogues |
03/05/1992 | WO1992003155A1 Product containing growth factor and glutamine and use of growth factor for the treatment of intestinal mucosa |
03/05/1992 | WO1992003154A1 Product and use of it for the treatment of catabolic states comprising authentic igf-1 and hypocaloric amount of nutritients |
03/05/1992 | WO1992003146A1 Therapeutically active mixture of glutathion and anthocyan compounds |
03/05/1992 | WO1992003130A1 Use of aryl hydroxyurea compounds for the treatment of atherosclerosis |
03/05/1992 | WO1991019707A3 Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones |